These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 199761)

  • 1. [Characteristics of alpha-toxin of Clostridium perfringens and its role in the pathogenesis of gas gangrene (author's transl)].
    Murata R; Ohsaka A
    Nihon Saikingaku Zasshi; 1977 Sep; 32(5):671-89. PubMed ID: 199761
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of alpha-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs.
    Kameyama S; Sato H; Murata R
    Jpn J Med Sci Biol; 1972 Jun; 25(3):200. PubMed ID: 4345498
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium perfringens toxins (type A, B, C, D, E).
    McDonel JL
    Pharmacol Ther; 1980; 10(3):617-55. PubMed ID: 6255496
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium perfringens vaccines.
    Titball RW
    Vaccine; 2009 Nov; 27 Suppl 4():D44-7. PubMed ID: 19837285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [alpha-toxin (phospholipase C) of Clostridium perfringens (author's transl)].
    Ohsaka A
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():121-44. PubMed ID: 194279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clostridium infections in leukemias and malignant neoplasms].
    Wallner G; Misiuna P; Cygan W; Cygan Z
    Pol Merkur Lekarski; 2004 Oct; 17(100):403-6. PubMed ID: 15690715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against Clostridium perfringens alpha-toxin.
    Nagahama M
    Curr Pharm Biotechnol; 2013; 14(10):913-7. PubMed ID: 24372250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gas gangrene--case diagnosis].
    Wojdat E; Kwiatek K; Zdrojewski H; Krupa L
    Przegl Epidemiol; 2005; 59(4):859-63. PubMed ID: 16729427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symposium II: Gas gangrene and toxins].
    Ito A
    Nihon Saikingaku Zasshi; 1974 Jan; 29(1):64-6. PubMed ID: 4365640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ultrastructural changes in skeletal muscles in experimental gas gangrene with Clostridium perfringens (author's transl)].
    Kaiserling E
    Zentralbl Allg Pathol; 1974; 118(2-3):182-95. PubMed ID: 4138778
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental investigations in guinea pigs on the therapy of gas gangrene with ozone. A preliminary report (author's transl)].
    Rotter M; Mittermayer H; Kundi M; Gruber H
    Wien Klin Wochenschr; 1974 Dec; 86(24):776-8. PubMed ID: 4373940
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of clostridial toxins in the pathogenesis of gas gangrene.
    Stevens DL; Bryant AE
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S93-S100. PubMed ID: 12173116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of toxins of Clostridium perfringens type A in infected animals by using the ELISA test].
    Nowakowska M; Bartoszcze M; Matras J
    Med Dosw Mikrobiol; 1989; 41(3-4):166-9. PubMed ID: 2561810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on animals on the use of pyrrolidino-methyl-tetracycline and penicillin G on the prophylaxis and therapy of gas gangrene].
    Klose F; Schallehn G
    Arzneimittelforschung; 1966 Nov; 16(11):1543-5. PubMed ID: 4299480
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock.
    Stevens DL; Bryant AE
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S160-4. PubMed ID: 9310664
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteritis necroticans (Pigbel) an unrecognised preventable disease?
    Murrell TG
    Chin Med J (Engl); 1982 Nov; 95(11):843-8. PubMed ID: 6299659
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diseases in man and animal caused by Clostridium perfringens and their relations].
    Köhler B
    Z Gesamte Hyg; 1973 Mar; 19(3):228-34. PubMed ID: 4353612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.